Search Within

Nelly G Adel

Formats
  1. Meeting Abstract (33)
  2. Journal Article (11)
Groups
  1. Department of Medicine (44)
  2. Hematologic Malignancies, Division of (43)
  3. Center for Hematologic Malignancies (35)
  4. Epidemiology and Biostatistics (25)
  5. Biostatistics Service (24)
  6. Bone Marrow Transplant (24)

More Groups

People
  1. Sean Devlin (19)
  2. Sergio Giralt (18)
  3. Hani Hassoun (11)
  4. Heather Landau (11)
  5. Juliet Barker (8)
  6. Sherry Mathew (8)

More People

Years
  1. 2017 (1)
  2. 2016 (5)
  3. 2015 (7)
  4. 2014 (5)
  5. 2013 (8)
  6. 2012 (5)

More Years

Publications
  1. Blood (21)
  2. Biology of Blood and Marrow Transplantation (8)
  3. Journal of Clinical Oncology (7)
  4. Bone Marrow Transplantation (5)
  5. Annals of Hematology (1)
  6. Journal of Oncology Pharmacy Practice (1)

More Publications

Publishers
  1. American Society of Hematology (21)
  2. Elsevier Inc. (8)
  3. American Society of Clinical Oncology (7)
  4. Nature Publishing Group (5)
  5. Elsevier Ltd (1)
  6. Sage Publications Ltd. (1)

More Publishers

Results (44)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Incidence, severity, day 100 treatment efficacy and therapy toxicity of cytomegalovirus (CMV) infections with early pre-emptive therapy in adult cord blood (CB) transplant recipients
    Meeting Abstract

    Lau, C.; Bhatt, V.; Dahi, P.; Devlin, S. M.; Yoo, Y.; Adel, N. G.; Mazis, C.; Perales, M. A.; Giralt, S. A.; Koehne, G.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Outcomes of rituximab for EBV viremia/post-transplant lymphoproliferative disease in CD34+ selected allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Poppiti, K.; Lin, A.; Adel, N. G.; Hilden, P.; Castro-Malaspina, H.
    Blood (2016)

    Fulltext@MSK | Save
  • Incidence, severity, day 100 treatment efficacy and therapy toxicity of cytomegalovirus (CMV) infections with early pre-emptive therapy in adult cord blood (CB) transplant recipients
    Meeting Abstract

    Lau, C.; Bhatt, V.; Dahi, P. B.; Devlin, S.; Yoo, Y.; Adel, N. G.; Mazis, C.; Perales, M.; Giralt, S. A.; Koehne, G.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Hypoalbuminemia is significantly associated with increased clearance time of high dose methotrexate in patients being treated for lymphoma or leukemia
    Journal Article

    Reiss, S. N.; Buie, L. W.; Adel, N.; Goldman, D. A.; Devlin, S. M.; Douer, D.
    Annals of Hematology (2016)

    Fulltext@MSK | Save
  • Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: Efficacy and cost analysis study
    Journal Article

    Afifi, S.; Adel, N. G.; Devlin, S.; Duck, E.; Vanak, J.; Landau, H.; Chung, D. J.; Lendvai, N.; Lesokhin, A.; Korde, N.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Reply to A. Indini et al.
    Journal Article

    Horvat, T. Z.; Adel, N. G.; Dang, T. O.; Momtaz, P.; Postow, M. A.; Callahan, M. K.; Carvajal, R. D.; Dickson, M. A.; D'Angelo, S. P.; Woo, K. M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Hypoalbuminemia is significantly associated with increased clearance time of high doses of methotrexate
    Meeting Abstract

    Reiss, S. N.; Buie, L. W.; Adel, N. G.; Goldman, D. A.; Devlin, S.; Douer, D.
    Blood (2015)

    Fulltext@MSK | Save
  • Incidence and management of proteasome inhibitor-related cardiotoxicity in multiple myeloma patients at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Land, J.; Afifi, S.; Adel, N. G.; Devlin, S.; Arora, A.; Lendvai, N.; Landgren, O.
    Blood (2015)

    Fulltext@MSK | Save
  • Effects of obesity on the efficacy and toxicity of induction chemotherapy in adult acute lymphoblastic leukemia (ALL)
    Meeting Abstract

    Peterson, T. J.; Lin, A.; Hilden, P.; Devlin, S.; Adel, N. G.; Park, J. H.
    Blood (2015)

    Fulltext@MSK | Save
  • Immune-related adverse events, need for systemic immunosuppression, and effects on survival and time to treatment failure in patients with melanoma treated with ipilimumab at Memorial Sloan Kettering Cancer Center
    Journal Article

    Horvat, T. Z.; Adel, N. G.; Dang, T. O.; Momtaz, P.; Postow, M. A.; Callahan, M. K.; Carvajal, R. D.; Dickson, M. A.; D'Angelo, S. P.; Woo, K. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save